Medical Devices
FDA Workshop: Implementation of Post Approval Studies for Medical Devices, June 4-5, 2009
Date, Time and Location
The meeting will be held on June 4, 2009 from 9:00 a.m. to 5 p.m. and June 5, 2009 from 9:00 a.m. to 12;00 noon at the following location:
Food and Drug Administration
Building 2, Room 2031
10903 New Hampshire Ave.
Silver Spring , MD 20993
* Please allow sufficient time for security screening.
Agenda
Day 1 (June 4)
| 8:00 am | Breakfast and Registration |
| 9:00 am | Welcome |
| 9:00 am | Daniel Schultz, MD, CDRH |
| 9:05 am | Susan Gardner, PhD, CDRH |
| 9:10 am | Donna-Bea Tilman, PhD, CDRH |
| Challenges in Patient Recruitment and Retention: (15 min each and one 10 min Q/A period) | |
| 9:15 am | Danica Marinac-Dabic, MD, Ph.D, CDRH, Workshop goals |
| 9:30 am | Todd Fonseca, Medtronic, Industry perspective on patient recruitment |
| 9:45 am | Danica Marinac-Dabic, MD, PhD, CDRH /OSB, Post-approval studies for medical devices: Challenges and opportunities |
| 10:00 am | Christine K. Pierre, RN, RxTrials, Inc., CRO perspective on patient recruitment |
| 10:15 am | Mark Boutin, JD, National Health Council, Patient perspective on clinical trialsparticipation |
| 10:30 am | Q & A period |
| 10:40 am | Coffee Break |
| 10:55 am | David Rutledge, PharmD , Abbott Vascular, Industry perspective on patient retention |
| 11:10 am | Mark Bray, PhD, Global Project Manager, CRO perspective on patient retention |
| 11:25 am | CDRH/ODE, Challenges in patient recruitment and retention: Bridging the premarket and postmarket |
| 11:40 am | Paul Gobel, Paul W. Goebel Consulting Inc, IRB considerations in implementing post-approval studies |
| 11:55 am | Q & A period |
| 12:05 pm | Lunch |
| Further Considerations in Implementing Post-Approval Studies : (15 min each and one 10 min Q/A period) | |
| 1:00 pm | Ken Getz, Center for Information & Study on Clinical Research Participation (CISCRP), Where are we now, where do we go from here? |
| 1:15 pm | Steven Pashko, PhD, Global Late Phase Studies, Pharmacovigilance and Safety Omnicare Clinical Research, Recruitment of clinical sites for post-approval studies |
| 1:30 pm | Gerry Prudhomme, JD, Hogan and Hartson, LLP, Legal consideration of post-approval studies |
| 1:45 pm | Solomon Iyasu, MD, PhD, CDER/ OSE, Drugs and Devices: Common considerations in implementing post-approval studies |
| 2:00 pm | Q & A period |
| 2:10 pm | Break |
| 2:20 pm | Break-out-Sessions: Recruitment and Retention of Participants (Attendees will be broken into two groups) Session I Leaders: Ellen Pinnow, MS, CDRH/OSB and Stan Harris, Wright Medical Technology Session II Leaders: Daniel Canos MPH, CDRH/OSB and Heidi Hinrichs, St. Jude Medical |
| 4:45 pm | Summary of Day 1, Danica Marinac-Dabic, MD, Ph.D, CDRH/OSB |
Day 2 (June 5)
| 8:00 am | Breakfast/Discussions |
| 9:00 am |
Summary of Break-out Session and Discussions: What have we learned: Identifying the critical issues Session I Leaders: Ellen Pinnow, MS, CDRH/OSB and Stan Harris, Wright Medical Technology Session II Leaders: Daniel Canos MPH, CDRH/OSB and Heidi Hinrichs, St. Jude Medical |
| 10:15 am | Break |
| 10:30 am | Panel Discussion: Where do we go from here: Identifying priorities and next steps Panelists include: Joel Batts, Wright Medical Technology Jodi Akin, MSN, Edwards Lifesciences Thomas Gross, MD, MPH, CDRH/OSB Malvina Eydelman, MD, CDRH/ODE Michael Domanski, MD, NIH/NHLBI CDRH/ODE Representative |
| 11:50 am | Summary Wrap-up, Danica Marinac-Dabic, MD, Ph.D, CDRH/OSB |
| 12:00 noon | End of Workshop |
Registration
Registration will be handled by Social and Scientific Systems. To register please email your name, title, organization affiliation, address, and email contact information to SZafonte@s-3.com.
Registration will be on a first-come, first served basis. Non-US citizens are subject to additional security screening, and should register as early as possible.
Contacts
The workshop organizer may be contacted at:
Ellen Pinnow
Epidemiologist
Division of Epidemiology
Office of Surveillance and Biometrics
Center for Devices and Radiological Health,
Food and Drug Administration
1350 Piccard Drive
Rockville, MD 20850
Phone: (240) 276-2373
e-mail: ellen.pinnow@fda.hhs.gov


